We are proud to announce the publication of our latest research article titled "A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey." This article summarizes the findings of the AwareNASH ...
Last Friday, the results of the CONVINCE trial were published in the prestigious New England Journal of Medicine. We are thrilled to announce that the CONVINCE study has shown that the use of high-dose hemodiafiltration led to a remarkable 23% low...
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...
On October 26, we presented the webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical TrialsDuring this webinar, our speaker and co-hosts, dived into Decentralized Clinical Trials and discuss the case stu...
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma”Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
On May 10, our partner ReSViNET presented the webinar: Progress in RSV Vaccines and Monoclonal AntibodiesIn this webinar, Professor Barney Graham, MD, PhD, shared his views on the lanscape of RSV therapeutics. The webinar was hosted by Prof. D...
On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...
On May 23, we presented the webinar: Why NASH trials frequently fail and how to improve themGuest speaker: Professor Manuel Castro Cabezas Host: Professor Diederick E. GrobbeeFill in the form and watch the replay: ...
On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trialsDuring this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:Cognitive domains – which ones sho...
"*" indicates required fields
"*" indicates required fields
